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ABSTRACT 23 
Matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) 24 
systems had not been officially launched for diagnostic use in clinical microbiology 25 
laboratories in China until 2012. Here, we reported the findings from the first large-scale 26 
evaluation study of Vitek MS for routine bacterial identification in two major diagnostic 27 
centers in Beijing and Hong Kong. A total of 2,266 unique isolates, representing 56 genera 28 
and 127 species were analyzed, and results were compared to those obtained by Vitek 2. 29 
Any discrepancies were resolved by 16S rRNA sequencing. Overall, Vitek MS provided 30 
correct identification for 2,246 (99.1%) isolates, including 2,193 (96.8%) isolates with correct 31 
species-level identifications and 53 (2.3%) isolates matched at genus level only. Vitek MS 32 
surpassed Vitek 2 consistently in species-level identification for the important pathogens, 33 
including non-Enterobacteriaceae Gram-negative bacilli (94.7%vs92%), Staphylococci 34 
(99.7%vs92.4%), Streptococci (92.6%vs79.4%), Enterococci (98.8%vs92.6%), and Clostridia 35 
(97.3%vs55.5). The findings demonstrated that the Vitek MS is highly accurate and reliable 36 
for routine bacterial identification in clinical settings in China.   37 
Keywords: MALDI-TOF MS, Vitek MS, bacterial identification  38 
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1. INTRODUCTION 39 
In an era of dramatic increase of drug resistance, rapid bacterial identification facilitates 40 
better management of antimicrobial therapies and infection control. Nowadays, semi-41 
automated biochemical test platforms such as Vitek 2 (BioMerieux, Marcy l’Etoile, France), 42 
or PHOENIX (BD Diagnostics, Sparks, MD, USA) are commonly used in clinical microbiology 43 
laboratories to complement the conventional cultured based method for routine bacterial 44 
identification, reducing the average time-to-identification to about 10 hours (Chatzigeorgiou 45 
et al. 2011). However, the reagent cost is extremely high in the laboratory settings in 46 
densely populated countries, such as China.  47 
The drawback can be potentially addressed by matrix-assisted laser desorption ionization-48 
time of flight mass spectrometry (MALDI-TOF MS), which was originally applied in 49 
biochemical industries for analysis of different macromolecules. The concept of microbial 50 
identification by measuring the unique bacterial proteomic fingerprints was firstly proposed 51 
about 30 years ago (Anhalt & Fenselau 1975). With the advent of automated algorithm in 52 
mass spectral acquisition and database-matching, bacterial identification can be performed 53 
in batchwise with an average reagent cost of less than 1 US dollar and the turnaround time 54 
of only a few minutes per sample. Numerous studies have described and compared the 55 
performance of two most common MALDI-TOF MS systems, the Bruker Biotyper (Bruker 56 
Daltonics, Germany) and the Vitek MS  (BioMerieux, Marcy l’Etoile, France), in identification 57 
of aerobic bacteria, anaerobes, yeasts and mycobacteria isolated from primary cultures 58 
(Chen et al. 2013; Garner et al. 2013; Manji et al. 2013; Rychert et al. 2013; Westblade et al. 59 
2013). The results consistently showed that MALDI-TOF MS offered equivalent or even 60 
superior accuracy in comparison to conventional phenotypic methods. Nevertheless, 61 
despite this promising data reported elsewhere, MALDI-TOF MS had not been officially 62 
launched for clinical use in China until the bioMerieux Vitek MS system was approved by the 63 
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China State Food and Drug Administration (SFDA) for in vitro diagnostic (IVD) purpose in 64 
2012. 65 
In the present study, we report the findings of a large scale evaluation of the Vitek MS IVD 66 
system for the identification of aerobic and anaerobic bacteria in two major diagnostic 67 
centers in Beijing and Hong Kong, two major cosmopolitan cities with good geographic 68 
representation of northern and southern China respectively.  To the best of our knowledge, 69 
no similar studies of this sample size have been performed in developing countries including 70 
China.   71 
 72 
2. MATERIALS AND METHODS 73 
2.1 Study sites.  The performance of the Vitek MS IVD system was evaluated at the 74 
Departments of Microbiology in Chinese People’s Liberation Army General Hospital (PLA 301 75 
Hospital) of Beijing and Queen Mary hospital (QMH) of Hong Kong. PLA 301 Hospital, which 76 
serves patients mostly from the North China regions, is the biggest military tertiary hospital 77 
in China with 3,500-beds and around 100,000 inpatients per year, whereas QMH is a tertiary 78 
referral university-affiliated acute hospital with 1,600 beds, serving a population of 0.53 79 
million resident in southern area of China.  80 
Prior to the initiation of the study, the operators in the two different study sites were 81 
trained by the same team of technical staff from BioMerieux so that the techniques used in 82 
Vitek MS target slide preparation, instrument operation and data interpretation were 83 
consistent with each other.  84 
2.2 Bacterial isolates. During a three-month period (March 2013 – May 2013), all aerobic 85 
and anaerobic bacterial isolates recovered from various clinical specimens, such as blood, 86 
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urine, stool, cerebrospinal fluid, wound swabs, throat swabs, sputum and other lower 87 
respiratory specimens, were collected for this study prospectively. 88 
Prior to MALDI-TOF MS analysis, bacterial isolates were recovered on appropriate agar 89 
media (Columbia horse blood agar for aerobes or facultative anaerobes and neomycin blood 90 
agar supplemented with hemin and vitamin K for anaerobes) under 35℃ incubation for 24h 91 
to 72h in aerobic, microaerophilic or anaerobic conditions as appropriate. Test results of the 92 
isolates from the same patients were deduplicated to ensure that a particular isolate was 93 
only tested once. 94 
2.3 Conventional bacterial identification. In each diagnostic centre, after the Gram staining 95 
and determination of catalase and oxidase activities, bacterial identification relied on semi-96 
automated biochemical test platforms, Vitek 2, using the GP, GN, NH or ANC cards 97 
(BioMerieux, Marcy l’Etoile, France) according to manufacturer’s instructions. The criterion 98 
used for the acceptance of species-level identifications obtained from Vitek 2 was that the 99 
isolates were identified as the only choice with a confidence value of ≥85%.  Genus-level 100 
identifications were reported when 2 to 3 species of the same genus were given.  A no 101 
identification (No ID) result was denoted as (i) single identification result with confidence 102 
value less than 85%, (ii) multiple identification results including species of different genera 103 
or (iii) an “no ID” flag was provided by Vitek 2 owing to no identification present in the 104 
system database. 105 
2.4 Vitek MS identification. Isolates were identified by Vitek MS system using a single 106 
deposit directly from bacterial colonies without any prior extraction step according to the 107 
manufacturer’s guideline. In brief, a portion of a fresh colony was applied onto an individual 108 
spot of the 48-wells Vitek MS-DS disposable target slide, followed by overlaying with 1μl 109 
ready-to-use Vitek MS Matrix solution ─ saturated solution of α-cyano-4-hydroxycinnamic 110 
acid in 50% acetonitrile and 2.5% trifluoroacetic acid (BioMerieux, Marcy l’Etoile, France). 111 
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After drying, the target plate was loaded onto the Vitek MS mass spectrometer for target 112 
interrogation. The system reported the best identification match(es) along with confidence 113 
value(s) from 0% to 99.9%. 114 
Samples returned with single identification results with any confidence values were 115 
considered as highly confidence at species level, whereas the result was only considered as 116 
genus level identification when the system proposed a split identification with any 117 
confidence values (low discrimination) that included species of the same genus. A “No ID” 118 
result was denoted if (i) no identification result was provided by the system or (ii) split 119 
identification result including species of different genera were given.  120 
Samples with “No ID” were retested with a single deposit and the repeated result was 121 
considered as the final result for that specimen. 122 
In addition to the Escherichia coli ATCC 8739, which served as the calibration control and 123 
internal identification control, Staphylococcus aureus ATCC 25923, Pseudomonas aeruginosa 124 
ATCC 10145 and Clostridium perfringens ATCC 13124 were used as the external positive 125 
control for Gram positive, Gram negative and anaerobic bacteria respectively. For quality 126 
control purpose, these external positive controls and the bacteria-free Vitek MS Matrix 127 
solution, which served as a negative control, were analyzed on each day of testing.  128 
2.5 Final reference identification and Discrepancy resolution. When the Vitek MS system 129 
proposed a species-level identification that was completely matched with that provided by 130 
Vitek 2, the result was considered as the final reference identification and no further 131 
investigation was performed.  132 
In case species-level identification was not available from either systems, or if there was 133 
mismatch between the two systems, bacterial DNA was extracted and mailed to Hong Kong 134 
for 16S rRNA sequencing. The resulting sequence was run through the Ridom and 135 
7 
 
16SpathDB databases to determine the final reference identification (Janda & Abbott 2007; 136 
Woo et al. 2011). 137 
A correct identification was defined as any result from Vitek MS and Vitek 2 concordant with 138 
the final reference identification at the species and/or genus level, whereas a 139 
misidentification (mis-ID) result was denoted when the bacterial identifications obtained 140 
from Vitek MS and Vitek 2 did not match with the final reference bacterial identification.  141 
2.6 Statistical analysis. Pearson’s Chi-square test or Fisher’s Exact test, where appropriate, 142 
were used to compare the results obtained by Vitek MS and Vitek II with the same specimen. 143 
Cohen’s kappa coefficients (κ) were also calculated to determine the level of agreement 144 
between two methods. 145 
  146 
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3. RESULTS 147 
3.1 Overall results. A total of 2,266 bacterial isolates were analyzed in this study. This 148 
included 1,581 aerobic Gram negative bacteria, 535 aerobic Gram positive bacteria and 150 149 
anaerobes, representing 56 genera and 127 species. Overall, Vitek MS correctly identified 150 
99.1% (2246/2266) of the isolates, including 96.8% (2193/2266) to the species level and an 151 
additional 2.3% (53/2266) to the genus level. The remaining 0.9% (20/2266) isolates were 152 
either misidentified (n=4) or denoted as no identification (n=16).   153 
3.2 Aerobic Gram-Negative Bacteria. The 1,581 aerobic Gram negative isolates collected in 154 
the study were categorized into the Enterobacteriaceae family (n=1,182) and non-155 
Enterobacteriaceae Gram negative organisms (n=399) (Table S1).  156 
Vitek MS results agreed with the reference final identification for 99.4% (1175/1182) of the 157 
Enterobacteriaceae isolates, with 97.1% (1148/1182) identified to species level and 2.3% 158 
(28/1182) corrected to the genus level only (Table S1). Correct species-level identification 159 
was consistently obtained for all isolates among 12 species (Enterobacter aerogenes, 160 
Enterobacter gergoviae, Enterobacter sakazakii, E. coli, Escherichia hermannii, Klebsiella 161 
oxytoca, Morganella morganii, Providencia rettgeri, Providencia stuartii, Serratia 162 
liquefaciens, Serratia marcescens and Salmonella typhi) whereas four species were more 163 
likely to have a correct genus-level ID rather than species level by using Vitek MS : Proteus 164 
vulgaris (n=17, 0% species, 100% genus), Raoultella ornithinolytica (n=4, 0% species, 75% 165 
genus, 25% no ID), Salmonella enterica ssp arizonae (n=1, 0% species, 100% genus) and 166 
Salmonella paratyphi A (n=1, 0% species, 100% genus). 167 
Vitek MS misidentified four isolates (two Shigella spp. isolates were misidentified as E. coli, 168 
one Raoultella ornithinolytica was misidentified as Enterobacter aerogenes and one Proteus 169 
mirabilis was misidentified as Proteus vulgaris / Proteus penneri) and failed to identify three 170 
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isolates (“no ID” for one each of Citrobacter freundii complex, Citrobacter koseri and 171 
Klebsiella pneumoniae).  172 
Vitek MS correctly reported 99.2% (396/399) of non-Enterobacteriaceae Gram negative 173 
organisms, which encompassed 38 species and 25 genera, to species level (94.7%, 378/399) 174 
or to genus but not species level (4.5%, 18/399) (Table S1). A total of 29 species of 175 
organisms, including those commonly encountered important pathogens, such as 176 
Acinetobacter baumannii complex (n=44), Pseudomonas aeruginosa (n=212) and 177 
Stenotrophomonas maltophilia (n=67), showed concordant species-level identification with 178 
the reference method for over 90% of their isolates. Some species, including Aeromonas 179 
caviae (n=4), Burkholderia pseudomallei (n=2), Ochrobacturm intermedium (n=2), 180 
Pseudomonas alcaligenes (n=1) and Pseudomonas otitidis (n=1), were only limited to genus-181 
level identification for all the isolates (0% species, 100% genus).  The three isolates that 182 
could not be identified with Vitek MS (i.e. “No ID” flaggings) included one each of 183 
Acinetobacter radioresistens, Campylobacter coli and Pasteurella dagmatis.  184 
3.3 Aerobic Gram-positive Bacteria. Among the 535 Gram-positive bacterial isolates (Table 185 
S2), the Staphylococci (n=357), Streptococci (n=68) and Enterococci (n=81) are the most 186 
commonly encountered pathogens in the clinical laboratories. In addition, 29 isolates of 187 
other Gram-positive cocci (n=9) and Gram-positive rods (n=20) were also collected during 188 
the study period (Table S2).   189 
Of the 357 staphylococci, all but one was correctly identified to species level by Vitek MS. 190 
The missing isolate was Staphylococcus lugdunensis, which was only corrected to genus level 191 
as multiple choices of species-level identification were given. Similarly, with the exception of 192 
one Enterococcus durans isolate, which was returned with “No ID” from the system, Vitek 193 
MS provided correct species-level identification for all the Enterococci. The species-level 194 
identification for the Streptococci appeared to be more challenging than Staphylococci and 195 
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Enterococci, with 63/68 (92.6%) of the isolates being correctly identified to the species level. 196 
In particular, only 75% of the Streptococcus bovis group, 77.8% of the Streptococcus 197 
dysgalactiae and 85.7% of the Streptococcus anginosus group were correctly identified to 198 
species level (Table S2). Nevertheless, the Vitek MS correctly differentiated Streptococcus 199 
pneumoniae from Streptococcus mitis group for all but one case. The final reference 200 
identification for this case was S. pneumoniae, the Vitek MS, however, reported a split 201 
identification between S. pneumoniae and S. mitis group. 202 
The remaining 29 Gram-positive organisms represented 9 additional genera. Vitek MS can 203 
readily provide 28 (96.6%) accurate identifications, with 27 (93.1%) corrected to species-204 
level. Only one isolate of Nocardia brasiliensis was reported as no identification (Table S2). 205 
3.4 Anaerobes. A total of 150 anaerobic bacterial isolates (8 genera and 19 species) were 206 
analyzed in this study.  The Vitek MS provided correct identification for 95.3% (143/150) of 207 
the isolates, including 94.0% (141/150) down to species-level and 1.3% (2/150) achieved 208 
genus-level. The remaining 4.7% (7/150) isolates were provided with “no ID” results by the 209 
system (Table S3). 210 
Vitek MS correctly identified 100% (28/28) and 97.3% (107/110) of the Bacteroides spp. and 211 
Clostridia spp., respectively. All the Clostridium difficile (n=85) and the 17 Clostridium 212 
perfringens (n=17) isolates were correctly identified to species level by Vitek MS. However, 213 
only 6 correct species-level identifications were obtained from those 12 non-Clostridia and 214 
non-Bacteroides anaerobes (Table S3). 215 
3.5  Vitek MS versus Vitek 2. The Vitek 2 system provided 2,237 (98.7%) correct 216 
identification to the species level (n=2096; 92.5%) and genus level (n=141; 6.2%) 217 
respectively. Comparison of performance in species-level identification between Vitek MS 218 
and Vitek 2 were summarized in Table 1. In brief, with the exception of Enterobacteriaceae, 219 
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non-Enterobacteriaceae Gram-negative organisms and Bacteroides, for which species-level 220 
identifications were performed equally well by both system, Vitek MS surpassed the 221 
performance of Vitek 2 for those clinically important pathogens, including the Staphylococci, 222 
Streptococci, Enterococci and  Clostridia. Conversely, Vitek 2 system demonstrated better 223 
performance in identifying the species of those non-Clostridia and non-Bacteroides 224 
anaerobes.  225 
The final reference identifications for the 20 organisms with “mis ID” and “no ID” obtained 226 
from Vitek MS were listed in Table 2.  227 
 228 
4 DISCUSSION 229 
MALDI-TOF MS systems have been demonstrated to be a fast, accurate and reliable 230 
technique for identification of clinical relevant bacteria in many countries. This was the first 231 
large-scale evaluation study of Vitek MS performed in China. The major strength of this 232 
study is the extensive breadth of tested clinical isolates from good geographic 233 
representation of northern and southern region of China.   234 
In this study, an almost perfect agreement between the identifications inferred by Vitek MS 235 
and those provided by phenotypic and genotypic reference methods was observed, with the 236 
overall concordance of 99.1%, which is better than those reported in Switzerland (94.7%) 237 
(Benagli et al. 2011), Netherlands (95.1%) (van Veen et al. 2010), France (96.2%) (Dubois et 238 
al. 2012).  239 
Among the isolates collected during the study period, more than 50% belonged to the 240 
Enterobacteriaceae family. In accordance with a previous study that evaluated Vitek MS 241 
performance for identification of Enterobacteriaceae (Richter et al. 2013), our study showed 242 
accurate genus- and species-level identifications for majority of isolates (99.4 %) with only a 243 
small number of misidentifications. There was no particular members of Enterobacteriaceae 244 
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for which the Vitek MS consistently failed except Shigella. It has been well-documented that 245 
Shigella spp. and E. coli are indistinguishable from each other using 16S rRNA sequencing or 246 
MALDI-TOF MS systems, which is attributed to the taxonomic similarity of these two 247 
organisms (Johnson 2000; van den Beld & Reubsaet 2012). The misidentification, however, 248 
is considered as a major drawback from clinical point of view, particularly for diagnosis of 249 
acute gastrointestinal infections that necessitates to be resolved by conventional 250 
biochemical tests, such as lactose fermentation and indole production or motility.   251 
Richter et al reported the inability of Vitek MS to discriminate the members of Citrobacter, 252 
such as C. freundii, C. youngae, C. braakii and C. werkmanii, and also the members of 253 
Enterobacter, such as E. asburiae, E. cloacae, E. hormaechei, and E. kobei (Richter, Sercia et 254 
al. 2013).  Fortunately, as the clinical significances and the drug susceptibilities among the 255 
members are similar, the impact of misidentification by Vitek MS on patient care is minimal 256 
(Janda et al. 1994; Paauw et al. 2008). In our study, these species were interpreted as 257 
“Citrobacter freundii complex” and “Enterobacter cloacae complex” with the accuracy of 258 
89.3% and 97.4% respectively, showing that this is probably the best approach to report 259 
MALDI-TOF MS results for these strains. 260 
For non-Enterobacteriaceae Gram-negative bacilli, our study showed that the Vitek MS IVD 261 
system showed correct genus and species identification for 99.2% of the tested isolates. The 262 
result was in consistent with a multicenter evaluation study performed in US (Manji, 263 
Bythrow et al. 2013). Manji et al evaluated the performance of Vitek MS v2.0 for 264 
identification of 558 unique non-Enterobacteriaceae Gram-negative bacilli in US and was 265 
returned with overall accurate species and genus identification of 90.9% (Manji, Bythrow et 266 
al. 2013). Likewise, Van Veen et al, using the Microflex LT instrument, showed that the 267 
system could achieve the genus and species identification to 94.3% with similar variety of 268 
tested strains in Europe (van Veen, Claas et al. 2010). It should be noted that incorrect 269 
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identification of non-Enterobacteriaceae Gram-negative bacilli always results in significant 270 
negative clinical impact, especially for species with high drug resistant rate, such as 271 
Acinetobacter baumannii complex, or for bacteria with limited therapeutic choices, such as 272 
Stenotrophomonas maltophilia (Dortet et al. 2006; Howard et al. 2012; Vila & Pachon 2012). 273 
No false identification was obtained in this study, indicating that Vitek MS is a reliable 274 
diagnostic tool for enhancing the management of infections associated with non-275 
Enterobacteriaceae Gram-negative bacilli in China.  276 
In clinical microbiology laboratories, distinguishing one species from another among some 277 
Gram positive bacteria, especially the coagulase-negative Staphylococci, the viridians group 278 
Streptococci and some Enterococci, is often unreliable and overly complicated using 279 
conventional biochemical methods (Ruoff 2011). It has been previously demonstrated that 280 
MALDI-TOF MS system provides accurate and reliable platform for identification of these 281 
Gram-positive aerobic bacteria (Moon et al. 2013; Rychert, Burnham et al. 2013). Consistent 282 
with the findings of those studies, we also experienced the significant better performance of 283 
Vitek MS than Vitek 2 in species identification of Gram-positive bacteria, especially 284 
Staphylococci (99.7%), Enterococci (98.8%) and Streptococci (92.6%). This is particularly 285 
important for diagnosis of sepsis and meningitis, in which identification to species level is 286 
necessary. Additionally, the Vitek MS was shown to readily differentiate S. pneumoniae from 287 
S. mitis group species in our study. This was recognized  as a strength of Vitek MS over 288 
MALDI Biotyper given that misidentifications of S. mitis group strains as S. pneumoniae by 289 
MALDI Biotyper were reported in several studies (Bizzini et al. 2010; Cherkaoui et al. 2010; 290 
Neville et al. 2011; McElvania Tekippe et al. 2013). However, this problem appears to have 291 
been overcome in the latest release of the Bruker Biotyper software (version 3.1; MBT-292 
BDAL-5627 MSP library, Bruker Daltonics) (Harju et al. 2014).  293 
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Anaerobic bacteria represent a group of major infectious agents identified in clinical 294 
microbiology laboratories. However, owing to the low doubling time and relatively inert 295 
biochemical reactivity, phenotypic identification methods, including the commercially 296 
available biochemical kits, can be both time-consuming and laborious, hindering the 297 
selection of appropriate therapy. The development of MALDI-TOF MS systems provides the 298 
opportunity for rapid and accurate identification of anaerobe (Nagy et al. 2009; Garner, 299 
Mochon et al. 2013). Importantly, Vitek MS correctly identified all of the 85 tested C. difficile 300 
isolates to species level, which facilitate the timely initiation of appropriate infection control 301 
measures to limit the spread of disease. Nevertheless, MALDI-TOF MS showed varied rates 302 
of identification for other anaerobes. Asides from Clostridia and Bacteroides, Vitek MS only 303 
correctly identified 2/3 of anaerobes to genus or species level. The finding was similar to 304 
other previous investigations, which only resulted in up to 61% correct species-level 305 
identifications for similar variety of strains (Seng et al. 2009; La Scola et al. 2011). This 306 
highlights the importance of extending the coverage of database with the mass spectra of 307 
additional reference strains to improve the identification capacity for anaerobes using 308 
MALDI-TOF MS. Nevertheless, since there were only a small number of isolates were 309 
analyzed for several rarely encountered species, the study findings may underestimate the 310 
system’s true capabilities in identification of anaerobes.  311 
In conclusion, Vitek MS offered equivalent or even superior accuracy in comparison to Vitek 312 
2 in identification of bacterial species among different clinically important pathogens. The 313 
introduction of Vitek MS system in our clinical laboratories would therefore facilitate 314 
shorter turnaround time with improved diagnostic accuracy for routine bacterial 315 
identification. With the current mass spectral reference database, Vitek MS is accurate and 316 
reliable for identification of nearly all aerobic bacteria, Clostridia spp. and Bacteroides spp. 317 
in our region. However, this technology still cannot completely supersede the biochemical 318 
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test panels, which are essential to supplement the areas of weakness of Vitek MS, such as 319 
the inability to differentiate Shigella species from E. coli and the suboptimal performance in 320 
identification of non-Clostridia and non-Bacteroides anaerobic bacteria. On the other hand, 321 
continuous expansion of Vitek MS spectral database is needed, particularly for anaerobic 322 
bacteria, in order to improve both the efficiency and the accuracy of Vitek MS in routine 323 
diagnostic microbiology.    324 
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Table S1: Identification results from Gram-negative aerobic bacteria obtained from Vitek MS and Vitek 2. 
 
Reference identification (no. of isolates) 
Vitek MS         Vitek 2       
 
No. (%) of isolates with correct ID to the level of 
 
No. (%) of isolates with correct ID to the level of 
 
Species
*
 Genus
†
 No ID
‡
 Mis ID
§
   Species Genus No ID Mis ID   
Enterobacteriaceae  (1,182) 1,148 (97.1) 27 (2.3) 3 (0.3) 4  (0.3) 
 
1,156 (97.8) 26  (2.2) 0 0 
 
Citrobacter freundii complex
||
 (28)  25   (89.3) 2   (7.1) 1 (3.6) 0 
 
28   (100) 0 0 0 
 
Citrobacter koseri (11) 10     (91) 0 1 (9) 0 
 
11   (100) 0 0 0 
 
Enterobacter aerogenes (35) 35   (100) 0 0 0 
 
35   (100) 0 0 0 
 
Enterobacter cloacae complex
¶ 
(76)  74   (97.4) 2   (2.6) 0 0 
 
74   (97.4) 2 (2.6) 0 0 
 
Enterobacter gergoviae (1) 1     (100) 0 0 0 
 
1     (100) 0 0 0 
 
Enterobacter sakazakii (2) 2     (100) 0 0 0 
 
2     (100) 0 0 0 
 
Escherichia coli (595) 595 (100) 0 0 0 
 
595 (100) 0 0 0 
 
Escherichia hermannii (1) 1     (100) 0 0 0 
 
1     (100) 0 0 0 
 
Klebsiella oxytoca (48) 48   (100) 0 0 0 
 
48   (100) 0 0 0 
 
Klebsiella pneumoniae (135) 134   (99.3) 1 (0.7) 0 0 
 
134   (99.3) 1   (0.7) 0 0 
 
Klebsiella ozaenae (1) 0 0 1 (100) 0 
 
1     (100) 0 0 0 
 
Morganella morganii (24) 24   (100) 0 0 0 
 
24   (100) 0 0 0 
 
Proteus mirabilis (146) 145  (99.3) 0 0 1 (0.7) 
 
146   (100) 0 0 0 
 
Proteus vulgaris (17) 0 17   (100) 0 0 
 
0 17   (100) 0 0 
 
Providencia rettgeri (3) 3     (100) 0 0 0 
 
3    (100) 0 0 0 
 
Providencia stuartii (3) 3     (100) 0 0 0 
 
3     (100) 0 0 0 
 
Raoultella ornithinolytica (4) 0 3   (75) 0 1  (25) 
 
0 4   (100) 0 0 
 
Serratia liquefaciens (1) 1     (100) 0 0 0 
 
1     (100) 0 0 0 
 
Serratia marcescens (46) 46   (100) 0 0 0 
 
46   (100) 0 0 0 
 
Salmonella enterica ssp arizonae (1) 0 1   (100) 0 0 
 
1     (100) 0 0 0 
 
Salmonella paratyphi A (1) 0 1   (100) 0 0 
 
1     (100) 0 0 0 
 
Salmonella typhi (1) 1     (100) 0 0 0 
 
1     (100) 0 0 0 
 
Shigella flexneri (1) 0 0 0 1  (100) 
 
0 1   (100) 0 0 
 
Shigella sonneii (1) 0 0 0 1  (100) 
 
0 1   (100) 0 0 
 
           Non-Enterobacteriaceae Gram-Negative 
organisms (399) 
378 (94.7) 18 (4.5) 3  (0.8) 0 
 
367 (92.0) 20 (5.0) 12 (3.0) 0 
 
Achromobacter xylosoxidans (5) 5   (100) 0 0 0 
 
5    (100) 0 0 0 
 
Acinetobacter baumannii complex (44) 40  (91.0) 4   (9.0) 0 0 
 
42 (95.4) 1  (2.3) 1 (2.3) 0 
 
Acinetobacter jonnosonii (1) 1 (100) 0 0 0 
 
0 0 1 (100) 0 
 
Acinetobacter radioresistens (1) 0 0 1  (100) 0 
 
1     (100) 0 0 0 
 
Acinetobacter ursingii (3) 3    (100) 0 0 0 
 
3     (100) 0 0 0 
 
Actinobacillus ureae (1) 1    (100) 0 0 0 
 
0 0 1 (100) 
  Aeromonas caviae (4) 0 4   (100) 0 0 
 
0 4    (100) 0 0 
 
Bergeyella zoohelcum (1) 1    (100) 0 0 0 
 
0 0 1 (100) 0 
 
Bordetella pertussis (1) 1     (100) 0 0 0 
 
0 0 1 (100) 0 
 
Burkholderia cepacia complex
#
 (4) 4   (100) 0 0 0 
 
4     (100) 0 0 0 
 
Burkholderia pseudomallei (2) 0 2   (100) 0 0 
 
2     (100) 0 0 0 
 
Campylobacter jejuni (2) 2    (100) 0 0 0 
 
0 0 2 (100) 0 
 
Campylobacter coli (1) 0 0 1  (100) 0 
 
0 0 1 (100) 0 
 
Chromobacterium violaceum (1) 1    (100) 0 0 0 
 
1    (100) 0 0 0 
 
Chryseobacterium indologenes (4) 4   (100) 0 0 0 
 
4   (100) 0 0 0 
 
Cupriavidus pauculus (1) 1    (100) 0 0 0 
 
1    (100) 0 0 0 
 
Delftia acidovorans (3) 3    (100) 0 0 0 
 
1    (33.3) 0 2   (66.6) 0 
 
Eikenella corrodens (1) 1 (100) 0 0 0 
 
1 (100) 0 0 0 
 
Elizabethkingia meningoseptica (3) 3     (100) 0 0 0 
 
3     (100) 0 0 0 
 
Haemophilus influenzae (2) 2    (100) 0 0 0 
 
2    (100) 0 0 0 
 
Haemophilus parahaemolyticus (1) 1    (100) 0 0 0 
 
1    (100) 0 0 0 
 
Moraxella osloensis (1) 1    (100) 0 0 0 
 
0 0 1   (100) 0 
 
Neisseria gonorrhoeae (2) 2   (100) 0 0 0 
 
1    (50) 1 (50) 0 0 
 
Ochrobacturm intermedium (2) 0 2   (100) 0 0 
 
0 1   (50) 1   (50) 0 
 
Pasteurella dagmatis (1) 0 0 1   (100)  0 
 
0 1   (100) 0 0 
 
Pasteurella multocida (4) 4   (100) 0 0 0 
 
0 4  (100) 0 0 
 
Plesiomonas shigelloides (1) 1    (100) 0 0 0 
 
1    (100) 0 0 0 
 
Pseudomonas aeruginosa (212) 209  (98.6) 3  (1.4) 0 0 
 
209  (98.6) 3   (1,4) 0 0 
 
Pseudomonas alcaligenes (1) 0 1   (100) 0 0 
 
0 1   (100) 0 0 
 
Pseudomonas otitidis (1) 0 1   (100) 0 0 
 
0 1   (100) 0 0 
 
Pseudomonas putida (8) 8    (100) 0 0 0 
 
6    (75) 2   (25) 0 0 
 
Ralstonia mannitolilytica (2) 1    (50) 1   (50) 0 0 
 
2    (100) 0 0 0 
 
Ralstonia pickettii (1) 1    (100) 0 0 0 
 
1    (100) 0 0 0 
 
Shewanella algae (6) 6    (100) 0 0 0 
 
6   (100) 0 0 0 
 
Stenotrophomonas maltophilia (67) 67  (100) 0 0 0 
 
66  (98.5) 1   (1.5) 0 0 
 
Vibrio cholerae (1) 1    (100) 0 0 0 
 
1    (100) 0 0 0 
 
Vibrio parahaemolyticus (2) 2    (100) 0 0 0 
 
2    (100) 0 0 0 
 
Vibrio vulnificus (1) 1    (100)   0     0     0 
 
    1    (100)     0     0    0 
 
           Total (1,581) 1,526 (96.6) 45  (2.8) 6 (0.4) 4  (0.2)  1,523 (96.3) 46  (2.9) 12   (0.8) 0 
 * 
Species-level identification was denoted when only one identification result was obtained from Vitek MS. 
† 
Genus-level identification was denoted when a split identification (low discrimination) that included species of the same genus was obtained from Vitek MS. 
‡ 
No ID was denoted when (i) multiple identifications that included species of different genera, or (ii)  “no ID” flagging was  obtained from Vitek MS. 
§
 Mis-ID was denoted when the bacterial identifications obtained from Vitek MS did not match with the final reference bacterial identification. 
||
Citrobacter freundii complex includes Citrobacter freundii, C. braakii, C. gilenii, C. murliniae, C. werkmanii and youngae.  
¶
Enterobacter cloacae complex includes Enterobacter cloacae, Enterobacter anigenus, Enterobacter intermedium and Enterobacter kobei.  
#
Burkholderia cepacia complex includes B. cepacia, B. multivorans, B. stabilis, B. vietnamiensis, B. ambifaria, B. anthina, B. pyrrocinia and genomovar III  and 
VI.
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Table S2: Identification results from Gram-positive aerobic bacteria obtained from Vitek MS and Vitek 2. 
 
Reference identification (no. of 
isolates) 
Vitek MS         Vitek 2       
 
No. (%) of isolates with correct ID to the level of 
 
No. (%) of isolates with correct ID to the level of 
 
Species
*
 Genus
†
 No ID
‡
 Mis ID
§
   Species Genus No ID Mis ID 
 
Staphylococcus (357) 356 (99.7) 1   (0.3) 0 0 
 
330 (92.4) 26 (7.3) 0 1   (0.3) 
 
Staphylococcus aureus (213) 213 (100) 0 0 0 
 
195 (91.5) 18 (18.5) 0 0 
 
Staphylococcus caprae (1) 1 (100) 0 0 0 
 
1 (100) 0 0 0 
 
Staphylococcus capitis (12) 12 (100) 0 0 0 
 
12 (100) 0 0 0 
 
Staphylococcus cohnii  (3) 3 (100) 0 0 0 
 
3 (100) 0 0 0 
 
Staphylococcus epidermidis (55) 55 (100) 0 0 0 
 
54 (98.2) 1 (1.8) 0 0 
 
Staphylococcus haemolyticus (16) 16 (100) 0 0 0 
 
15 (93.8) 1 (6.2) 0 0 
 
Staphylococcus hominis (41) 41 (100) 0 0 0 
 
37 (90.2) 4 (9.8) 0 0 
 
Staphylococcus lugdunensis (9) 8 (88.9) 1   (11.1) 0 0 
 
8 (88.9) 0 0 1   (11.1) 
 
Staphylococcus saprophyticus (3) 3 (100) 0 0 0 
 
2 (66.7) 1 (33.3) 0 0 
 
Staphylococcus sciuri (2) 2 (100) 0 0 0 
 
2 (100) 0 0 0 
 
Staphylococcus simulans (1) 1 (100) 0 0 0 
 
1 (100) 0 0 0 
 
Staphylococcus schleiferi (1) 1 (100) 0 0 0 
 
0 1 (100) 0 0 
 
           
Enterococcus (81) 80   (98.8) 0 1 (1.2) 0 
 
75   (92.6) 4    (4.9) 0 2   (2.5) 
 
Enterococcus avium (4) 4  (100) 0 0 0 
 
4 (100) 0 0 0 
 
Enterococcus casseliflavus (4) 4  (100) 0 0 0 
 
3 (75) 1 (25) 0 0 
 
Enterococcus faecalis (27) 27 (100) 0 0 0 
 
27 (100) 0 0 0 
 
Enterococcus faecium (38) 38 (100) 0 0 0 
 
35 (92.1) 2 (5.3) 0 1 (2.6) 
 
Enterococcus gallinarum (4) 4  (100) 0 0 0 
 
3 (75) 1 (25) 0 0 
 
Enterococcus durans (4) 3 (75) 0 1 (25) 0 
 
3 (75) 0 0 1 (25) 
 
           
Streptococcus (68) 63   (92.6) 4    (5.9) 1 (1.5) 0 
 
54   (79.3) 10   (14.7) 2 (3) 2  (3) 
 
Streptococcus agalactiae (12) 12 (100) 0 0 0 
 
10 (83.3) 2 (16.7) 0 0 
 
Streptococcus bovis group
||
 (4) 3 (75) 0 1 (25) 0 
 
3 (75) 1 (25) 0 0 
 
Streptococcus dysgalactiae (9) 7 (77.8) 2    (22.2) 0 0 
 
9 (100) 0 0 0 
 
Streptococcus anginosus group
¶
 (7) 6 (85.7) 1    (14.3) 0 0 
 
3 (42.9) 3 (42.9) 0 1 (14.2) 
 
Steptococcus gallolyticus (1) 1 (100) 0 0 0 
 
1 (100) 0 0 0 
 
Steptococcus gordonii(1) 1 (100) 0 0 0 
 
1 (100) 0 0 0 
 
Streptococcus mitis group
#
 (11) 11 (100) 0 0 0 
 
8 (72.7) 2 (18.2) 0 1 (9.1) 
 
Steptococcus parasanguinis (1) 1 (100) 0 0 0 
 
1 (100) 0 0 0 
 
Streptococcus pneumoniae (10) 9  (90) 1    (10) 0 0 
 
9  (90) 1 (10) 0 0 
 
Streptococcus pyogenes (5) 5  (100) 0 0 0 
 
5 (100) 0 0 0 
 
Streptococcus salivarius (4) 4  (100) 0 0 0 
 
3  (75) 1 (25) 0 0 
 
Streptococcus sanguinis (1) 1 (100) 0 0 0 
 
1 (100) 0 0 0 
 
Streptococcus suis (2) 2 (100) 0 0 0 
 
0 0 2 (100) 0 
 
           
Other Gram-positive cocci (9) 9   (100) 0 0 0 
 
7    (77.8) 2   (22.2) 0 0 
 
Granulicatella adiacens (1) 1 (100) 0 0 0 
 
1 (100) 0 0 0 
 
Lactococcus garvieae (1) 1 (100) 0 0 0 
 
0 1 (100) 0 0 
 
Micrococcus luteus (6) 6  (100) 0 0 0 
 
6 (100) 0 0 0 
 
Pediococcus acidilactici (1) 1 (100) 0 0 0 
 
0 1 (100) 0 0 
 
           
Gram-positive rods (20) 18  (90) 1   (5) 1 (5) 0 
 
9   (45) 3   (15) 8 (40) 0 
 
Arcanobacterium haemolyticum (2) 2  (100) 0 0 0 
 
2  (100) 0 0 0 
 
Arcanobacterium pyogenes (1) 1  (100) 0 0 0 
 
1  (100) 0 0 0 
 
Bacillus cereus group
¤
 (4) 4  (100) 0 0 0 
 
0 0 4 (100) 0 
 
Bacillus circulans(1) 1  (100) 0 0 0 
 
0 0 1 (100) 0 
 
Bacillus megaterium (1) 1 (100) 0 0 0 
 
0 0 1 (100) 0 
 
Corynebacterium jerkerium(1) 1(100) 0 0 0 
 
1 (100) 0 0 0 
 
Corynebacterium striatum (3) 3 (100) 0 0 0 
 
1 (33.3) 1 (33.3) 1 (33.3) 0 
 
Corynebacterium urealyticum (2) 2 (100) 0 0 0 
 
2 (100) 0 0 0 
 
Listeria monocytogenes (3) 3 (100) 0 0 0 
 
1 (33.3) 2 (66.7) 0 0 
 
Listeria ivanovii (1) 0 1 (100) 0 0 
 
1 (100) 0 0 0 
 
Nocardia brasiliensis (1) 0 0 1 (100) 0 
 
0 0 1 (100) 0 
 
           
Total (535) 526 (98.3) 6   (1.1) 3 (0.6) 0   475 (88.8) 45   (8.4) 10 (1.9) 5  (0.9) 
 
* 
Species-level identification was denoted when only one identification result was obtained from Vitek MS. 
† 
Genus-level identification was denoted when a split identification (low discrimination) that included species of the same genus was obtained from Vitek MS. 
‡ 
No ID was denoted when (i) multiple identifications that included species of different genera, or (ii)  “no ID” flagging was  obtained from Vitek MS. 
§
 Mis-ID was denoted when the bacterial identifications obtained from Vitek MS did not match with the final reference bacterial identification. 
|| 
Streptococcus bovis group includes S. bovis, S. alactolyticus, S. infantarius and S. gallolyticus. 
¶
Streptococcus anginosus group includes S. anginosus, S. constellatus and S. intermedius. 
#
 Streptococcus mitis group includes S. sanguis, S. parasanguis, S. gordonii, S. crista, S. oralis, S. mitis, S. peroris and S. infantis. 
¤
Bacillus cereus group includes Bacillus cereus, Bacillus thuringiensis and Bacillus mycoides.
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Table S3: Identification results from anaerobic bacteria obtained from Vitek MS and Vitek 2.  
  
      
 
Reference identification (no. of isolates) 
Vitek MS       
 
Vitek 2       
 
No. (%) of isolates with correct ID to the level 
of  
No. (%) of isolates with correct ID to the level of 
 
Species
*
 Genus
†
 No ID
‡
 
Mis 
ID
§
 
  Species Genus No ID Mis-ID 
 
Clostridia (110) 107 (97.3) 0 3  (2.7) 0 
 
61 (55.5) 49 (44.5) 0 0 
 
Clostridium bifermentans (2) 2   (100) 0 0 0 
 
0 2   (100) 0 0 
 
Clostridium butyricum (1) 1   (100) 0 0 0   0 1   (100) 0 0 
 
Clostridium difficile (85) 85 (100) 0 0 0 
 
42 (49.4) 43 (50.6) 0 0 
 
Clostridium innocuum (2) 0 0 2   (100)  0 
 
0 2   (100) 0 0 
 
Clostridium novyi (1) 0 0 1   (100)  0 
 
0 1   (100) 0 0 
 
Clostridium perfringens (17) 17 (100) 0 0 0 
 
17  (100) 0 0 0 
 
Clostridium ramosum (1) 1   (100) 0 0 0 
 
1    (100) 0 0 0 
 
Clostridium septicum (1) 1   (100) 0 0 0 
 
1    (100) 0 0 0 
 
           
Bacteroides (28) 28 (100) 0 0 0 
 
28 (100) 0 0 0 
 
Bacteroides vulgatus (4) 4 (100) 0 0 0 
 
4 (100) 0 0 0 
 
Bacteroides thetaiotaomicron (3) 3 (100) 0 0 0 
 
3 (100) 0 0 0 
 
Bacteroides ovatus (6) 6 (100) 0 0 0 
 
6 (100) 0 0 0 
 
Bacteroides fragilis (15) 15 (100) 0 0 0 
 
15 (100) 0 0 0 
 
           
Other anaerobes (12) 6  (50) 2   (16.7) 4   (33.3) 0 
 
9    (75) 1   (8.3) 2  (16.7) 0 
 
Actinomyces europaeus (1) 1   (100) 0 0 0 
 
0 0 1 (100) 0 
 
Atopobium parvulum (1) 0 0 1   (100)  0 
 
0 0 1 (100) 0 
 
Eggerthella lenta (4) 0 2    (50) 2   (50) 0 
 
4    (100) 0 0 0 
 
Propionibacterium avidum (1) 0 0 1   (100)  0 
 
0 1   (100) 0 0 
 
Propionibacterium acnes (1) 1    (100) 0 0 0 
 
1    (100) 0 0 0 
 
Finegoldia magna (1) 1    (100) 0 0 0 
 
1    (100) 0 0 0 
 
Parvimonas micra (3) 3    (100) 0 0 0 
 
3    (100) 0 0 0 
 
           
           
Anaerobes (150) 141 (94.0) 2   (1.3) 7 (4.7) 0   98 (65.4) 50 (33.3) 2 (1.3) 0 
 
* 
Species-level identification was denoted when only one identification result was obtained from Vitek MS. 
† 
Genus-level identification was denoted when a split identification (low discrimination) that included species of the same genus was obtained from Vitek MS. 
‡ 
No ID was denoted when (i) multiple identifications that included species of different genera, or (ii)  “no ID” flagging was  obtained from Vitek MS. 
§
 Mis-ID was denoted when the bacterial identifications obtained from Vitek MS did not match with the final reference bacterial identification. 
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Table 1: Comparison of performance in species-level identification between Vitek MS and Vitek 2 
Bacterial group No. of isolates 
Percentage (%) of species-level 
identification kappa / p value 
Vitek MS Vitek 2 
Enterobacteriaceae 1,182 97.1 97.8 0.863 / 0.598 
Non-Enterobacteriaceae Gram-
negative organism 
399 94.7 92 0.484 / 0.074 
Staphylococcus 357 99.7 92.4 0.066 / <0.01 
Streptococcus 68 92.6 79.4 0.134 / <0.01 
Enterococcus 81 98.8 92.6 0.270 / 0.043 
Gram-positive rods 20 90 45 0.031 / <0.01 
Clostridia  110 97.3 55.5 0.067 / <0.01 
Bacteroides 28 100 100 n.a.
*
 
Non-Clostridia and non-
Bacteroides anaerobes 
12 50 75 0.100 / 0.023 
Anaerobes (Overall) 150 94 65.4 0.037 / 0.011 
* 
Cohen’s kappa coefficients (κ) cannot be calculated as the results from both methods are not variable.   
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Table 2: Final reference identifications for the 20 isolates with mis ID or no ID obtained from Vitek MS 
Final reference ID  
No. of 
isolates 
Identities given by 
Vitek MS   (Confidence value) Vitek 2    (Confidence value) 16S rRNA 
Citrobacter freundii complex 1 No ID                                  Citrobacter braakii (97%)  Citrobacter murliniae 
Citrobacter koseri 1 No ID Citrobacter koseri (99%) Citrobacter koseri  
Klebsiella ozaenae
*
 1 No ID no ID Klebsiella ozaenae 
Proteus mirabilis 1 Proteus penneri (50.0%);    
Proteus vulgaris (50.0%) 
Proteus mirabilis (99%) Proteus mirabilis  
Raoultella ornithinolytica 1 Enterobacter aerogenes (99.9%) 
Raoultella ornithinolytica (99%); 
Raoultella planticola (97%) 
Raoultella ornithinolytica 
Shigella flexneri  1 E. coli (99.9%) Shigella flexneri (99.9%) Shigella flexneri  
Shigella sonneii 1 E. coli (99.9%) Shigella sonneii (99.9%) Shigella sonneii 
Acinetobacter radioresistens 
 
1 
 
No ID 
Acinetobacter 
radioresistens(99.9%) 
Acinetobacter radioresistens 
Campylobacter coli 1 No ID no ID Campylobacter coli 
Pasteurella dagmatis* 1 
 
No ID 
Pasteurella dagmatis (99%); 
Pasteurella stomatis(97%) 
Pasteurella dagmatis 
Streptococcus bovis group 1 
 
No ID Streptococcus bovis (96%); 
Streptococcus equinus(91%) 
Streptococcus 
bovis/Streptococcus 
gallolyticus  
Enterococcus durans 1 No ID  Enterococcus gallinarum (88%) Enterococcus durans 
Nocardia brasiliensis
*
 1 No ID No ID Nocardia brasiliensis 
Clostridium innocuum
*
 2 No ID No ID Clostridium innocuum 
Clostridium novyi
*
 1 No ID No ID Clostridium novyi  
Atopobium parvulum
*
 1 No ID No ID Atopobium parvulum 
Eggerthella lenta 2 No ID Eggerthella lenta Eggerthella lenta 
Propionibacterium avidum 1 
 
No ID 
Propionibacterium granulosum 
(91%); Propionibacterium 
propionicus (88%) 
Propionibacterium avidum 
* 
Species absent from database 
 
 
 
23 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 448 
